PDP
PDP
Skip to content Skip to navigation menu
Your browser is not supported by this site.
Please update to the latest version, or use a different browser for the best experience.
Guide to Biosimilars Litigation and Regulation in the U.S., 2021-2022 ed.

Author(s):

Product details:

Brand: Thomson West
Copyright: 2021
ISBN: 9781731999665
Publication Frequency: Updated as changes in the law dictate
Update format: N/A

Free update period with subscription:

90 days  (details)

Can we help?

Contact Us 
Call 1-888-728-7677
THOMSON REUTERS PROVIEW eBOOK EDITION

Guide to Biosimilars Litigation and Regulation in the U.S., 2021-2022 ed.

106740957

106740957
106740956
ProView eBook (Learn more)
$179.00

Monthly pricing (What's this?)
$14.00/month


Guide to Biosimilars Litigation and Regulation in the U.S. is an understandable guide and go-to reference, providing expert and practical guidance for attorneys working in this burgeoning area of the law.

The title explores each section of the Biologics Price Competition and Innovation Act (BPCIA) as well as an overview of legal and regulatory issues unique to biosimilars that have arisen or are expected to arise in litigation concerning biosimilar products.

This resource also includes discussion of the 20+ cases making their way through the judicial system.

Related statutes and regulations, agency guidance, and other relevant materials are included in the extensive appendices.

Features

  • Analyzes current case law
  • Provides relevant FDA guidance
  • Analyzes current case law
  • Provides relevant FDA guidance